Thomas Trimarchi serves as Executive at BridgeBio Pharma, Inc., where they oversee executive responsibilities. Since joining the company, Thomas Trimarchi has executed 10 insider transactions totaling $4.1M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 12, 2025 involved selling 13,826 shares valued at $1.0M.
Thomas Trimarchi currently holds 369,004 shares of BridgeBio Pharma, Inc. (BBIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas Trimarchi has been a net seller of BBIO stock. They have purchased $0 and sold $4.1M worth of shares.
Thomas Trimarchi's most recent insider trade was on Dec 12, 2025, when they sold 13,826 shares at $75.15 per share.
Get notified when new Form 4 filings are submitted
| $66.19 |
| Discretionary |
| Nov 17, 2025 | BBIO | $464.9K | Sale | 6,956 | $66.84 | Discretionary |
| Nov 16, 2025 | BBIO | $1.4M | Payment | 21,317 | $66.39 | Discretionary |
| Aug 21, 2025 | BBIO | $2.1M | Sale | 42,237 | $49.48 | Discretionary |
| Aug 18, 2025 | BBIO | $100.5K | Sale | 1,973 | $50.94 | Discretionary |
| Aug 18, 2025 | BBIO | $771.2K | Sale | 15,380 | $50.14 | Discretionary |
| Aug 16, 2025 | BBIO | $1.1M | Payment | 21,317 | $51.32 | Discretionary |
| Aug 16, 2024 | BBIO | $437.6K | Payment | 17,936 | $24.40 | Discretionary |
| Aug 6, 2024 | BBIO | $0 | Award | 19,003 | $N/A | Discretionary |